40
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prognostic Potency of Plasma LRG1 Measurement at Multiple Time Points in Acute Ischemic Stroke Patients

ORCID Icon, &
Pages 181-190 | Received 28 Aug 2023, Accepted 30 Jan 2024, Published online: 05 Mar 2024

References

  • Bathla G , AjmeraP , MehtaPMet al. Advances in acute ischemic stroke treatment: current status and future directions. Am. J. Neuroradiol.44(7), 750–758 (2023).
  • Deng G , ChuYH , XiaoJet al. Risk factors, pathophysiologic mechanisms, and potential treatment strategies of futile recanalization after endovascular therapy in acute ischemic stroke. Aging Dis.14(6), 2096–2112 (2023).
  • Ferrari F , MorettiA , VillaRF. Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity. Neural Regen. Res.17(2), 292–299 (2022).
  • Nair R , WagnerAN , BuckBH. Advances in the management of acute ischemic stroke. Curr. Opin. Neurol.36(2), 147–154 (2023).
  • Robbins BT , HowingtonGT , SwaffordK , ZummerJ , WoolumJA. Advancements in the management of acute ischemic stroke: a narrative review. J. Am. Coll. Emerg. Physicians Open4(1), e12896 (2023).
  • Alsbrook DL , DiNapoli M , BhatiaKet al. Neuroinflammation in acute ischemic and hemorrhagic stroke. Curr. Neurol. Neurosci. Rep.23(8), 407–431 (2023).
  • Duan H , SongP , LiR , SuH , HeL. Attenuating lipid metabolism in atherosclerosis: the potential role of anti-oxidative effects on low-density lipoprotein of herbal medicines. Front. Pharmacol.14, 1161657 (2023).
  • Perez-Vega C , DomingoRA , TripathiSet al. Influence of glucose levels on clinical outcome after mechanical thrombectomy for large-vessel occlusion: a systematic review and meta-analysis. J. Neurointerv. Surg.14(1), doi: 10.1136/neurintsurg-2021-017771 (2022).
  • Generoso G , JanovskyC , BittencourtMS. Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis. Curr. Opin. Endocrinol. Diabetes Obes.26(2), 109–116 (2019).
  • Lee NT , OngLK , GyawaliPet al. Role of purinergic signalling in endothelial dysfunction and thrombo-inflammation in ischaemic stroke and cerebral small vessel disease. Biomolecules11(7), 994 (2021).
  • Kang H , MaX , LiuJ , FanY , DengX. High glucose-induced endothelial progenitor cell dysfunction. Diab. Vasc. Dis. Res.14(5), 381–394 (2017).
  • Yang J , YinGN , KimDKet al. Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation. Exp. Mol. Med.55(5), 1013–1022 (2023).
  • He S , RyuJ , LiuJet al. LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance. J. Clin. Invest.131(24), e148545 (2021).
  • Wang X , AbrahamS , MckenzieJaGet al. LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling. Nature499(7458), 306–311 (2013).
  • Cai D , ChenC , SuY , TanY , LinX , XingR. LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling. J. Gastrointest. Oncol.13(1), 400–412 (2022).
  • Hasan TF , RabinsteinAA , MiddlebrooksEHet al. Diagnosis and management of acute ischemic stroke. Mayo Clin. Proc.93(4), 523–538 (2018).
  • Li LH , ChenCT , ChangYC , ChenYJ , LeeIH , HowCK. Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune inflammation index in acute ischemic stroke: a STROBE-compliant retrospective study. Medicine100(25), e26354 (2021).
  • Choi CHJ , BarrW , ZamanSet al. LRG1 is an adipokine that promotes insulin sensitivity and suppresses inflammation. Elife11, e81559 (2022).
  • Chwal BC , DosReis RCP , SchmidtMI , DuncanBB , BarretoSM , GriepRH. Levels and correlates of risk factor control in diabetes mellitus – ELSA-Brasil. Diabetol. Metab Syndr.15(1), 4 (2023).
  • Sarkar A , ChakrabortyD , KumarV , MalhotraR , BiswasS. Upregulation of leucine-rich alpha-2 glycoprotein: a key regulator of inflammation and joint fibrosis in patients with severe knee osteoarthritis. Front. Immunol.13, 1028994 (2022).
  • Miao Y , WangM , CaiX , ZhuQ , MaoL. Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFbeta1)/SMAD signaling pathway. Bioengineered13(3), 7316–7327 (2022).
  • Nakajima H , NakajimaK , SeradaS , FujimotoM , NakaT , SanoS. The involvement of leucine-rich alpha-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model. Mod. Rheumatol.31(6), 1120–1128 (2021).
  • Zhong B , ChengB , HuangXet al. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling. Cell Death Dis.13(1), 16 (2021).
  • Dritsoula A , DowsettL , PilottiC , O’ConnorMN , MossSE , GreenwoodJ. Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway. Sci. Rep.12(1), 4867 (2022).
  • Wang Y , XuJ , ZhangXet al. TNF-alpha-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis. Cell Death Dis.8(3), e2715 (2017).
  • Yang FJ , HsiehCY , ShuKHet al. Plasma leucine-rich alpha-2-glycoprotein 1 predicts cardiovascular disease risk in end-stage renal disease. Sci. Rep.10(1), 5988 (2020).
  • Warner JJ , HarringtonRA , SaccoRL , ElkindMSV. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke50(12), 3331–3332 (2019).
  • Jadhav AP , MokinM , Ortega-GutierrezSet al. An appraisal of the 2018 guidelines for the early management of patients with acute ischemic stroke. Interv. Neurol.8(1), 55–59 (2020).
  • Al Alawi AM , AlBusaidi I , AlShibli Eet al. Health outcomes after acute ischemic stroke: retrospective and survival analysis from Oman. Ann. Saudi Med.42(4), 269–275 (2022).
  • Lin Y , SchulzeV , BrockmeyerMet al. Endovascular thrombectomy as a means to improve survival in acute ischemic stroke: a meta-analysis. JAMA Neurol.76(7), 850–854 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.